ChemBriefBioNTech to shutter sites in Germany, Singapore as no buyers emerge
BioNTech will close manufacturing sites in Germany and Singapore after failing to find buyers, resulting in up to 1,860 job cuts. This restructuring follows the transfer of COVID-19 vaccine production
reuters · 2026-09-28 06:08 UTC